On Sept. 11, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
CBP said the FDA will hold an extended downtime from Sept. 13 10 p.m. through 6 a.m. Sept. 14 ET as the agency installs a critical security update, according to a Sept. 12 cargo systems message.
On Sept. 10, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 8, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 5, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
The FDA is developing a list, called a "green list," aimed at preventing the importation of glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredients (APIs) from unverified foreign sources, according to an agency release.
On Sept. 4, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
On Sept. 3, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On Sept. 2, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The FDA is amending its food additive regulations to allow for the safe use of vitamin D3 as a nutrient supplement in yogurt and other cultured dairy products fermented with Lactobacillus delbrueckii, subspecies bulgaricus (L. delbrueckik), subsp. bulgaricus), and Streptococcus thermophilus (S. thermophilus) at a level higher than is currently permitted, it said in a Federal Register notice.